Biomedical Cluster - Skolkovo Community

- All site RSS

Cluster News

A shot in the arm for Skolkovo’s biomed cluster
The recent appointment of Yuri Nikolsky at the Skolkovo Foundation’s biomed technologies cluster appears to be bearing fruit already: The pharmaceuticals guru says several new companies are about...
12.08.2014, Статьи

Beating down doors to new heart disease drug
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary...
31.07.2014, Статьи

Job Fair at Skolkovo’s Biomed Cluster
Photos from the event >>>
07.07.2014, Фотогалерея

Skolkovo will take part in the largest biotech expo BIO 2014
The Skolkovo Foundation will participate in 2014 BIO International Convention, the international biotechnology exhibition, which will take place in San Diego, USA on 23-26 June 2014. As the world’s...
18.06.2014, Новости кластера Биомед

Baltic Sea Health Summit
Since 3-5 June, 2014 in Finland (Turku city) was conducted Baltic Sea Health Summit – the biggest forum in pharmaceutical, biotechnology and medical industries in Baltic Sea countries (www.bshs.eu...
18.06.2014, Новости кластера Биомед

InBioMed Selected the Best Three
InBioMed, a unique contest that spanned several clusters to select the best biomedical startup projects and projects finding uses for nuclear technologies in health care, finished at Startup Village, having...
09.06.2014, Новости

Therapies of the future, a world level symposium
May 26 through 28, The Skolkovo Institute of Science and Technology (Skoltech) hosted Russia’s largest scientific symposium on the development of biomedicine in Russia and globally, titled Therapies...
30.05.2014, Статьи

The Biomedical Cluster at Netherlands took part in a Life Science Program
Life Sciences Health is one of the leading sectors in Dutch economy and if we look back to the history, biotechnologies were started to develop here many years ago. The first microscope was developed by...
19.05.2014, Статьи

The success of Eydos-Medicine on the global market
Eydos-Medicine, a resident of the Biomed Cluster of the Skolkovo Foundation and a leading Russian integrated developer of robotic simulators, supplied the first Surgery Simulator to US-based company Covidien...
16.05.2014, Новости

Discussions on the release of new medicines on the market have taken place at Skolkovo
The Skolkovo Foundation's Biomedical Technologies Cluster, in conjunction with the companies OST Rus and GCT, held the first ever educational seminar, 'The release of medicines onto the market...
13.05.2014, Новости

Skolkovo at the Molecular Diagnostics – 2014 conference
The 8th All-Russian Conference Molecular Diagnostics – 2014 was held in Moscow on March 18-20. The conference was attended by foreign participants, and included relevant Skolkovo projects for the...
26.03.2014, Статьи

Startups – Fusion Pharma to fight myelogenous leukemia
Biomedicine is the area which demonstrates best of all the highest level of Russian science. Though some experts claim countries like the US are preeminent in biomedical ventures, there are a bunch of...
21.02.2014, Пресса о нас

BIND RUS opens new R&D center in Moscow
BIND RUS, Russian pharmaceutical resident company of the Biomedical Cluster of Skolkovo Foundation, opened new R&D center on the territory of Technopark «Slava» on 6 February The company...
11.02.2014, Статьи

Hepatera, a Skolkovo resident company, completes enrollment of Phase IIa clinical trial of Myrcludex B, a novel entry inhibitor for treatment of chronic HBV infection
A resident of the Russian Innovation Center Skolkovo Hepatera is developing an innovative drug candidate - Myrcludex B - for treatment of chronic viral hepatitis B and D in close cooperation with the German...
10.02.2014, Новости кластера Биомед

Pharmaceutical Executive Magazine: Russia's Bet on Biopharma
What to do? Contributing to public health goals is one approach, as Novartis has done in importing to Russia a hypertension management and control program originally developed for Canada in cooperation...
31.01.2014, Пресса о нас